Doctors are being asked to preserve units of the new RSV shot, as demand is outweighing supply.
U.S. health officials have asked doctors to prioritize which infants get the new RSV shot, just as cases of the respiratory disease begin to rise with the onset of cold and flu season.
The federal agency is also recommending doctors stop giving the shot, which is sold under the brand name Beyfortus, to infants 8 to 19 months old who are eligible for palivizumab, an older antibody injection sold under the brand name Synagis used to prevent severe RSV in children at increased risk due to heart and lung conditions.
In addressing the"great need" for RSV prevention products, the FDA approved Beyfortus for newborns and infants in July, and the CDC began recommending it the next month, just before the season which typically begins in mid-September.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
A seasonal viral stew is brewing with flu, RSV, COVID and moreNational data shows COVID-19 levels are moderate. In most of the U.S., levels of other respiratory viruses are low, although RSV is ticking up in some southeastern states.
Read more »
State tracking COVID, flu, and RSV cases in new online dashboardThe Alabama Department of Public Health has launched a new dashboard for tracking respiratory viruses.
Read more »
CDC issues alert over high RSV vaccine demandRSV is a cold-like nuisance for most people, and not as well-known as the flu but packs hospitals every winter.
Read more »
CDC updates RSV shot recommendations due to drug shortagesThe agency updated its guidance in response to limited supply of an antibody drug designed to protect infants from the potentially fatal respiratory disease.
Read more »
CDC updates RSV shot recommendations due to drug shortagesThe Centers for Disease Control and Prevention issued a health alert Monday in response to limited supplies of an antibody drug designed to protect infants from the respiratory disease RSV.
Read more »
CDC Warns of Shortage of RSV Shots to Protect BabiesDemand for a new shot that protects babies against respiratory syncytial virus (RSV) has outpaced supply, prompting U.S. health officials to recommend the doses be saved for high-risk infants. In an alert posted Monday afternoon, the U.S. Centers for Disease Control and...
Read more »